tirzepatide trade names is a weekly subcutaneous injection, sold under the brand Mounjaro (mainly for type 2 diabetes) and Zepbound (mainly for obesity). It works as a dual agent, activating both glucagon-like peptide-1 ( trade name for tirzepatide Mounjaro

In a landmark Phase 2 obesity trial, participants receiving the highest dose achieved: Up to ~24% average weight loss at 48 weeks Weight loss had not yet plateaued at the end of the study Potential for even greater reductions with longer treatment duration For context: Semaglutide (GLP-1): ~15% weight loss Tirzepatide (GIP + GLP-1): ~2123% weight loss Retatrutide (GIP + GLP-1 + Glucagon): ~24%+ weight loss in Phase 2 studies Common side effects were similar to other GLP-1based therapies and included nausea, vomiting, diarrhea, constipation, and abdominal discomfort, primarily during dose escalation

Aprende a rotar los puntos de inyeccin para medicamentos GLP-1 como Mounjaro y obtn tu receta en menos de 24 horas por 25 , vlida en cualquier farmacia

Research Focus: Investigation into metabolic regulation, glycemic control, and dual-incretin receptor pathways

Aroor, A

Another study revealed that ketogenic diet intervention reduced social deficits, repetitive behaviors, memory impairments, and inflammatory markers such as TNF-, IL- 1, and IL- 6 in BTBR rats [47]

Commercial -CGN is a random copolymer of -CGN and mu ()-CGN in the approximate ratio of 95:5